Nuvalent News

Nuvalent's Promising Clinical Progress and Financial Stability Support Strong Buy Rating

TipRanksMay 10 20:26

Nuvalent Q1 Net Loss Widens

Nuvalent (NUVL) reported a Q1 net loss Thursday of $0.69 per diluted share, widening from a loss of $0.44 a year earlier. Analysts surveyed by Capital IQ expected a loss of $0.67 per share. The clinic

MT NewswiresMay 9 19:19

Nuvalent | 10-Q: Quarterly report

Futu NewsMay 9 18:47 · Announcements

Nuvalent(NUVL.US) Director Sells US$2.61 Million in Common Stock

$Nuvalent(NUVL.US)$ Director Shair Matthew sold 37,500 shares of common stock on May 6, 2024 at an average price of $69.48 for a total value of $2.61 million.Source: Announcement What is statement of

Futu NewsMay 9 05:36

Nuvalent Insider Sold Shares Worth $2,605,525, According to a Recent SEC Filing

Matthew Shair, Director, on May 06, 2024, sold 37,500 shares in Nuvalent (NUVL) for $2,605,525. Following the Form 4 filing with the SEC, Shair has control over a total of 1,698,720 shares of the comp

MT NewswiresMay 9 05:22

Nuvalent(NUVL.US) Officer Sells US$216.2K in Common Stock

$Nuvalent(NUVL.US)$ Officer Miller Deborah Ann sold 3,000 shares of common stock on May 2, 2024 at an average price of $72.07 for a total value of $216.2K.Source: Announcement What is statement of cha

Futu NewsMay 4 05:30

Nuvalent(NUVL.US) Director Sells US$2.67 Million in Common Stock

$Nuvalent(NUVL.US)$ Director Shair Matthew sold 39,500 shares of common stock on Apr 29, 2024 at an average price of $67.51 for a total value of $2.67 million.Source: Announcement What is statement of

Futu NewsMay 2 05:21

Nuvalent Insider Sold Shares Worth $2,666,555, According to a Recent SEC Filing

Matthew Shair, Director, on April 29, 2024, sold 39,500 shares in Nuvalent (NUVL) for $2,666,555. Following the Form 4 filing with the SEC, Shair has control over a total of 1,736,220 shares of the co

MT NewswiresMay 2 05:05

Nuvalent(NUVL.US) Director Sells US$2.39 Million in Common Stock

$Nuvalent(NUVL.US)$ Director Shair Matthew sold 37,500 shares of common stock on Apr 22, 2024 at an average price of $63.65 for a total value of $2.39 million.Source: Announcement What is statement of

Futu NewsApr 25 05:28

We're Not Very Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring reve

Simply Wall StApr 22 20:49

Jefferies Starts Nuvalent at Buy, Cites Lung Cancer Drug Candidates

Seeking AlphaApr 18 21:54

Nuvalent(NUVL.US) Director Sells US$327.61K in Common Stock

$Nuvalent(NUVL.US)$ Director Conley Emily sold 5,000 shares of common stock on Apr 15, 2024 at an average price of $65.52 for a total value of $327.61K.Source: Announcement What is statement of change

Futu NewsApr 18 05:28

Nuvalent(NUVL.US) Director Sells US$2.46 Million in Common Stock

$Nuvalent(NUVL.US)$ Director Shair Matthew sold 37,500 shares of common stock on Apr 15, 2024 at an average price of $65.56 for a total value of $2.46 million.Source: Announcement What is statement of

Futu NewsApr 18 05:28

Nuvalent Insider Sold Shares Worth $2,458,335, According to a Recent SEC Filing

Matthew Shair, Director, on April 15, 2024, sold 37,500 shares in Nuvalent (NUVL) for $2,458,335. Following the Form 4 filing with the SEC, Shair has control over a total of 1,813,220 shares of the co

MT NewswiresApr 18 04:51

Nuvalent Initiated at Buy by Jefferies

Nuvalent Initiated at Buy by Jefferies

Dow JonesApr 17 20:06

Jefferies Initiates Coverage On Nuvalent With Buy Rating, Announces Price Target of $97

Jefferies analyst Roger Song initiates coverage on Nuvalent with a Buy rating and announces Price Target of $97.

Analyst UpgradesApr 17 19:57

Nuvalent(NUVL.US) Director Sells US$2.57 Million in Common Stock

$Nuvalent(NUVL.US)$ Director Shair Matthew sold 37,500 shares of common stock on Apr 8, 2024 at an average price of $68.44 for a total value of $2.57 million.Source: Announcement What is statement of

Futu NewsApr 11 05:27

Nuvalent Insider Sold Shares Worth $2,566,479, According to a Recent SEC Filing

Matthew Shair, Director, on April 08, 2024, sold 37,500 shares in Nuvalent (NUVL) for $2,566,479. Following the Form 4 filing with the SEC, Shair has control over a total of 1,850,720 shares of the co

MT NewswiresApr 11 04:51

Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024

Preclinical data continue to support NVL-330's broad activity against HER2 oncogenic alterations, selectivity over wild-type EGFR, and differentiated brain-penetrant profile .

Investing.com Apr 9 04:54

Nuvalent Presents New Preclinical Data For HER2-Selective Inhibitor, NVL-330, And ROS1-Selective Inhibitor, Zidesamtinib, At AACR Annual Meeting 2024

Preclinical data continue to support NVL-330's broad activity against HER2 oncogenic alterations, selectivity over wild-type EGFR, and differentiated brain-penetrant profile Zidesamtinib shown to be e

BenzingaApr 9 04:36